{"result": "(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>Harrison Principios de Medicina Interna is a medical textbook that provides comprehensive information on internal medicine, including adrenal disorders.)\n##\n(\"entity\"<|>EUROPEAN SOCIETY OF ENDOCRINOLOGY<|>ORGANIZATION<|>The European Society of Endocrinology is a professional organization that provides clinical practice guidelines for the management of adrenal incidentalomas.)\n##\n(\"entity\"<|>UPTODATE<|>ORGANIZATION<|>UpToDate is a clinical decision support resource that provides evidence-based information on various medical topics, including adrenal incidentalomas.)\n##\n(\"entity\"<|>ADENOMAS<|>EVENT<|>Adenomas are benign tumors of the adrenal gland that are often found incidentally during imaging studies.)\n##\n(\"entity\"<|>CARCINOMAS<|>EVENT<|>Carcinomas are malignant tumors that can develop in the adrenal glands, with a higher likelihood in larger incidentalomas.)\n##\n(\"entity\"<|>DHEA-S<|>PERSON<|>DHEA-S is a steroid hormone produced by the adrenal glands, which can be measured to assess adrenal function in patients with incidentalomas.)\n##\n(\"entity\"<|>TAC<|>EVENT<|>TAC, or computed tomography, is an imaging technique used to evaluate adrenal nodules and differentiate between adenomas and carcinomas.)\n##\n(\"entity\"<|>RMN<|>EVENT<|>RMN, or magnetic resonance imaging, is another imaging modality used to characterize adrenal nodules, particularly for assessing lipid content.)\n##\n(\"relationship\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>EUROPEAN SOCIETY OF ENDOCRINOLOGY<|>Both organizations provide guidelines and information related to the management of adrenal disorders, including incidentalomas<|>5)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY OF ENDOCRINOLOGY<|>UPTODATE<|>Both organizations offer clinical guidelines and resources for healthcare professionals regarding adrenal incidentalomas<|>5)\n##\n(\"relationship\"<|>ADENOMAS<|>CARCINOMAS<|>Adenomas and carcinomas are both types of tumors that can occur in the adrenal glands, with adenomas being benign and carcinomas being malignant<|>7)\n##\n(\"relationship\"<|>DHEA-S<|>ADENOMAS<|>DHEA-S levels can be indicative of adrenal function and are relevant in the assessment of adrenal adenomas<|>6)\n##\n(\"relationship\"<|>DHEA-S<|>CARCINOMAS<|>DHEA-S levels may also be relevant in assessing the potential for malignancy in adrenal tumors, including carcinomas<|>6)\n##\n(\"relationship\"<|>TAC<|>ADENOMAS<|>TAC is used to evaluate adrenal nodules, helping to differentiate between benign adenomas and malignant tumors<|>8)\n##\n(\"relationship\"<|>RMN<|>ADENOMAS<|>RMN is utilized to characterize adrenal nodules, particularly in assessing their lipid content, which is crucial for identifying adenomas<|>8)\n##\n(\"relationship\"<|>TAC<|>CARCINOMAS<|>TAC is also used to identify characteristics of adrenal carcinomas, aiding in the diagnosis of malignancy<|>8)\n##\n(\"relationship\"<|>RMN<|>CARCINOMAS<|>RMN can help in the assessment of adrenal carcinomas by providing detailed imaging of the adrenal glands<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: y carcinomas se basan en el diferente contenido de lípidos y en la diferente vascularización.\n\nEl tratamiento quirúrgico está reservado para los nódulos que por su tamaño o crecimiento sean molestos o exista la sospecha de malignidad, y para los nódulos hiperfuncionantes. En principio está claro que los nódulos con tamaño superior a los 6 cm tienen indicación quirúrgica, ya que en alguna serie se ha descrito que, entre estos, el 25% serán carcinomas y el 18%, metástasis.\n\nReferencias:\n- Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.\n- Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentaloma: European Society of Endocrinology Clinical Practice. Guideline in collaboration with the European Network for the Study of adrenal tumors. Eur J Endocrinol. 2016;175:G1-G34.\n- Recasens Sala M. Incidentaloma adrenal. Manual de Endocrinología y Nutrición. Disponible en: https://manual.seen.es (última modificación: 25 de noviembre de 2015).\n- Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrinology. 13.ª ed. Philadelphia.: Elsevier; 2016. p. 490-555.\n- Young WF, Jr, Kebebew E. The adrenal incidentaloma. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com. Literature review current through: Apr. 2019.\n\n## 37. Indique qué es verdad en los incidentalomas suprarrenales:\n\nA. Se sospecha malignidad cuando la radiodensidad es de más 10 unidades Hounsfield.\nB. Únicamente se debe medir DHEA-S en mujeres.\nC. Uno de cada cuatro incidentalomas mayores de 6 cm de diámetro son malignos.\nD. La adrenalectomía por laparoscopia está indicada en tumores de 6 cm o más de diámetro.\n---\n# SUPRARRENALES\n\n## COMENTARIO\n\nEn más del 85% de los casos, los incidentalomas suprarrenales se corresponden con adenomas benignos y no funcionantes.\n\nLa TAC y la RMN constituyen las pruebas de elección para el estudio de imagen de los nódulos suprarrenales. Las diferencias entre adenomas y carcinomas se basan en el diferente contenido de lípidos y en la diferente vascularización.\n\nLos criterios radiológicos sugerentes de adenoma suprarrenal son los bordes bien definidos, el contenido homogéneo y un coeficiente de atenuación inferior a 10 unidades Hounsfield (UH), representativo del alto contenido en lípidos, en la TAC sin contraste. Los incidentalomas suprarrenales con una densidad entre 10 y 40 UH deben someterse a otras exploraciones, y los incidentalomas suprarrenales con más de 40 UH son sospechosos de malignidad. En la TAC con contraste, un lavado rápido (más del 60% de lavado absoluto a los 15 min) también será sugerente de adenoma. En cuanto a la RMN, la mayor aportación para la caracterización del nódulo suprarrenal es el chemical shift (CS). Esta técnica se utiliza para detectar el contenido lipídico y es el método no invasivo más sensible y específico para diferenciar adenoma de metástasis. El adenoma, por su contenido lipídico, aparecerá más oscuro (pérdida de señal) en las imágenes fuera de fase (CS positivo).\n\nDHEA-S es un andrógeno suprarrenal que se produce bajo el estímulo de la ACTH y, por este motivo, su determinación puede ser útil en el estudio funcional de secreción autónoma de cortisol en el incidentaloma suprarrenal. Un nivel de DHEA-S suprimido sugiere una secreción suprimida crónicamente de ACTH y, por lo tanto, puede ser sugerente de secreción autónoma de cortisol por la lesión evaluada.\n\nEl tratamiento quirúrgico está reservado para los nódulos que por su tamaño o crecimiento sean molestos o exista la sospecha de malignidad, y para los nódulos hiperfuncionantes. En principio está claro que los nódulos con tamaño superior a los 6 cm tienen indicación quirúrgica, ya que en alguna serie se ha descrito que, entre estos, el 25% serán carcinomas y el 18%, metástasis.\n\nLa adrenalectomía abierta se recomienda siempre que existan sospechas de malignidad (>6 cm), y aun cuando a pesar de no existir ninguna sospecha de malignidad, la lesión presente un tamaño muy grande (>10 cm).\n\nReferencias:\n- Arlt W.\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}